Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

PubWeight™: 5.02‹?› | Rank: Top 1%

🔗 View Article (PMC 3278052)

Published in Chest on February 01, 2012

Authors

Susan R Kahn1, Wendy Lim, Andrew S Dunn, Mary Cushman, Francesco Dentali, Elie A Akl, Deborah J Cook, Alex A Balekian, Russell C Klein, Hoang Le, Sam Schulman, M Hassan Murad, American College of Chest Physicians

Author Affiliations

1: Department of Medicine, McGill University, Montreal, QC, Canada.

Articles citing this

(truncated to the top 100)

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88

Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.55

Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis. J Thromb Thrombolysis (2014) 2.07

VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest (2015) 1.99

Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus. J Thromb Haemost (2014) 1.98

Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med (2012) 1.60

A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med (2014) 1.56

When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data. Blood (2015) 1.48

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2015) 1.47

Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury. Thromb Haemost (2015) 1.43

Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study. J Clin Oncol (2014) 1.39

Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials (2016) 1.38

The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int (2016) 1.36

Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.34

Homogeneous low-molecular-weight heparins with reversible anticoagulant activity. Nat Chem Biol (2014) 1.20

Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. Can J Gastroenterol Hepatol (2014) 1.19

Pulmonary embolism in sickle cell disease: a case-control study. J Thromb Haemost (2012) 1.12

Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am (2013) 1.10

Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis (2012) 1.06

Chemoenzymatic synthesis of heparan sulfate and heparin. Nat Prod Rep (2014) 1.03

Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig Dis Sci (2012) 0.98

Anticoagulants: A Review of the Pharmacology, Dosing, and Complications. Curr Emerg Hosp Med Rep (2013) 0.95

Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88

A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial. Crit Care (2013) 0.88

Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res (2016) 0.88

Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist (2013) 0.87

Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction. Int J Med Sci (2012) 0.87

Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients. J Oncol (2014) 0.87

Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol (2014) 0.86

Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. World J Gastroenterol (2014) 0.86

Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis. Blood Transfus (2013) 0.85

Effects of long-term head-down-tilt bed rest and different training regimes on the coagulation system of healthy men. Physiol Rep (2013) 0.83

External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc (2014) 0.83

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit. Crit Care (2014) 0.83

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review. Ther Clin Risk Manag (2015) 0.82

Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J (2013) 0.82

Assessment of Venous Thromboembolism Prophylaxis in Neurological Patients with Restricted Mobility - VTE-NEURO Study. Maedica (Buchar) (2014) 0.81

Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis (2016) 0.81

A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China. PLoS One (2015) 0.81

Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost (2012) 0.80

Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a quasi-experimental study. BMC Med Inform Decis Mak (2012) 0.80

Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis (2015) 0.80

Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis. Onco Targets Ther (2016) 0.80

The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism. AJR Am J Roentgenol (2013) 0.79

Implementation of vertical clinical pharmacist service on venous thromboembolism prophylaxis in hospitalized medical patients. Einstein (Sao Paulo) (2014) 0.78

Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients. Hosp Pharm (2016) 0.78

Pattern of Venous Thromboembolism Occurrence in Gynecologic Malignancy: Incidence, Timing, and Distribution a 10-Year Retrospective Single-institutional Study. Medicine (Baltimore) (2015) 0.78

Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study. BMJ Open (2016) 0.78

Preventing VTE in Outpatients With Cancer. Chest (2012) 0.78

Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol (2016) 0.77

Venous thromboembolism following major orthopedic surgery. Maedica (Buchar) (2013) 0.77

Prevention of venous thromboembolism in medical intensive care unit: a multicenter observational study in Korea. J Korean Med Sci (2014) 0.77

White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study. PLoS One (2013) 0.77

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients. Ther Clin Risk Manag (2014) 0.77

Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature. Med Oral Patol Oral Cir Bucal (2016) 0.77

Thrombolysis during extended cardiopulmonary resuscitation for autoimmune-related pulmonary embolism. World J Emerg Med (2015) 0.77

The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome. Rheumatol Int (2014) 0.77

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study. Oncologist (2017) 0.76

Educational outreach visits to improve venous thromboembolism prevention in hospitalised medical patients: a prospective before-and-after intervention study. BMC Health Serv Res (2013) 0.76

Ameboma: an unusual cause of gastrointestinal bleeding during severe leptospirosis. BMC Infect Dis (2014) 0.76

Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. J Thromb Thrombolysis (2014) 0.76

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients. Vasc Health Risk Manag (2013) 0.76

A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illness. Thromb J (2015) 0.75

Study of clinical profile and management of patients with pulmonary embolism - single center study. Indian Heart J (2014) 0.75

Ambulatory Status Protects against Venous Thromboembolism in Acute Mild Ischemic Stroke Patients. J Stroke Cerebrovasc Dis (2016) 0.75

Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux. Drug Des Devel Ther (2013) 0.75

Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence. Int J Gynecol Cancer (2015) 0.75

Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities. Thromb Res (2015) 0.75

[Thromboprophylaxis in critically ill children in Spain and Portugal]. An Pediatr (Barc) (2014) 0.75

Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis (2013) 0.75

Phlegmasia cerulea dolens in a teenage boy found to have Factor V Leiden. BMJ Case Rep (2015) 0.75

What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention? J Emerg Trauma Shock (2014) 0.75

Variations in risk assessment models may contribute to the existing gap between venous thromboembolism prophylaxis guidelines and adherence. Springerplus (2012) 0.75

Transitions in the Prophylaxis, Treatment and Care of Patients with Venous Thromboembolism. Adv Ther (2015) 0.75

Effects of Exercise and Nutrition on the Coagulation System During Bedrest Immobilization. Medicine (Baltimore) (2015) 0.75

Antifactor Xa levels in critically ill Korean patients receiving enoxaparin for thromboprophylaxis: a prospective observational study. J Korean Med Sci (2013) 0.75

Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 0.75

Intervention for diagnosis of deep vein thrombosis in acute stroke patients: a hospital-based study. PLoS One (2014) 0.75

Trousseau's syndrome in a patient with advanced stage gastric cancer. World J Gastroenterol (2015) 0.75

Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute Infection. Int J Med Sci (2015) 0.75

Prophylaxis of venous thromboembolism in medical patients: too much or too little? Clin Epidemiol (2012) 0.75

Air travel considerations for the patients with heart failure. Iran Red Crescent Med J (2014) 0.75

Venous thromboembolism risk assessment in hospitalised patients: a new proposal. Clinics (Sao Paulo) (2013) 0.75

Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease. Dig Dis Sci (2013) 0.75

Characterization of immune cells and perforin mutations in familiar venous thromboembolism. Int J Clin Exp Med (2015) 0.75

Venous thromboprophylaxis in gastrointestinal bleeding. Can J Gastroenterol Hepatol (2015) 0.75

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome? Indian J Crit Care Med (2014) 0.75

Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature. Blood Transfus (2014) 0.75

Do pregnant women have a higher risk for venous thromboembolism following air travel? Adv Biomed Res (2015) 0.75

Venous thromboembolism prophylaxis in mental healthcare: do the benefits outweigh the risks? BJPsych Bull (2015) 0.75

Compromised natural killer cells in pulmonary embolism. Int J Clin Exp Pathol (2015) 0.75

Venous thromboembolism in children with cancer - a population-based cohort study. Thromb Res (2013) 0.75

Systemic lupus erythematosus and thrombosis. Thromb J (2015) 0.75

Thigh length versus knee length antiembolism stockings for the prevention of deep vein thrombosis in postoperative surgical patients; a systematic review and network meta-analysis. BMJ Open (2016) 0.75

New onset S wave in pulmonary embolism: revisited (something old and something new). BMJ Case Rep (2013) 0.75

Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients. Thrombosis (2015) 0.75

Internal relationship between symptomatic venous thromboembolism and risk factors: up-regulation of integrin β1, β2 and β3 levels. Am J Transl Res (2015) 0.75

Bleeding complications in critically ill patients with liver cirrhosis. Korean J Intern Med (2016) 0.75

Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients. Ther Clin Risk Manag (2014) 0.75

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism. J Blood Med (2015) 0.75

Articles cited by this

(truncated to the top 100)

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet (2002) 14.06

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med (2005) 12.99

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med (2004) 10.41

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10

Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90

Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med (2006) 7.89

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2004) 7.87

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst (2005) 7.70

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA (2008) 7.13

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88

Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet (2001) 6.37

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24

Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA (2005) 6.16

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med (2010) 5.79

Travel and risk of venous thrombosis. Lancet (2000) 5.23

Risk factors for venous thromboembolism. Circulation (2003) 4.64

Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59

Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.50

Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet (2009) 4.50

A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet (2000) 4.38

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2000) 4.29

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med (2002) 4.18

Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med (2006) 4.10

Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med (2010) 3.91

Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost (2006) 3.49

Severe pulmonary embolism associated with air travel. N Engl J Med (2001) 3.43

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost (2004) 3.36

Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med (2007) 3.33

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ (1994) 3.18

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.14

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum (2007) 3.12

To clot or not to clot? That is the question in central venous catheters. Clin Radiol (2004) 2.85

Venous thromboembolism and cancer: risks and outcomes. Circulation (2003) 2.68

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer (2001) 2.58

Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.55

Venous thrombosis after long-haul flights. Arch Intern Med (2003) 2.50

Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med (2004) 2.34

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest (2007) 2.32

Activation of coagulation system during air travel: a crossover study. Lancet (2006) 2.32

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28

Air travel and venous thromboembolism: a systematic review. J Gen Intern Med (2007) 2.21

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer (2005) 2.20

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13

A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost (2010) 2.08

Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol (2006) 2.03

A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg (2005) 2.03

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol (2008) 2.03

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost (2009) 1.95

A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol (2004) 1.92

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol (1991) 1.91

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol (2006) 1.89

Statins and blood coagulation. Arterioscler Thromb Vasc Biol (2004) 1.89

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med (2005) 1.87

Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 1.85

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost (2004) 1.85

Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev (2008) 1.79

Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev (2006) 1.77

Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med (2003) 1.75

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess (2005) 1.71

Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care (2004) 1.69

New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest (2000) 1.69

Meta-analysis: travel and risk for venous thromboembolism. Ann Intern Med (2009) 1.69

Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis. World J Surg (2010) 1.68

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol (2006) 1.67

Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67

Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66

Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (2002) 1.65

Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest (1998) 1.59

Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport. Arch Intern Med (2003) 1.57

Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med (2008) 1.54

No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Chest (2007) 1.51

Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med (2000) 1.51

The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol (2008) 1.50

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA (2009) 1.46

Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient. J Hosp Med (2006) 1.46

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus (2008) 1.45

High risk of the critically ill for venous thromboembolism. Crit Care Med (1982) 1.45

Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study. Thromb Haemost (2010) 1.42

Should patients with stroke wear compression stockings to prevent venous thromboembolism? Ann Intern Med (2010) 1.42

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group. Cancer (1994) 1.41

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) (2002) 1.40

Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest (2011) 1.36

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. J Clin Oncol (1996) 1.35

Chemotherapy-induced thrombosis. Thromb Res (2006) 1.34

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med (2006) 1.27

Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM (2000) 1.27

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27

Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg (1992) 1.24

Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost (2005) 1.23

Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology (2002) 1.22

Articles by these authors

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86

Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J (2006) 10.77

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 10.75

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95

ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol (2009) 7.94

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12

A guide for the design and conduct of self-administered surveys of clinicians. CMAJ (2008) 6.72

High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med (2011) 6.56

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2008) 6.39

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ (2009) 6.27

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88

Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA (2005) 5.46

Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.27

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10

A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ (2002) 4.84

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.82

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.50

Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

Need for expertise based randomised controlled trials. BMJ (2005) 4.34

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 4.30

Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest (2005) 4.29

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.87

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 3.86

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.81

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81

Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest (2001) 3.77

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.74

The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med (2011) 3.68

Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.56

Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55

The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med (2010) 3.47

Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46

GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44

The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med (2013) 3.43

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ (2009) 3.39

Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med (2002) 3.36

Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.36

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med (2007) 3.33

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.31

GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ (2011) 3.28

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA (2006) 3.26

Validity of composite end points in clinical trials. BMJ (2005) 3.26

Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet (2006) 3.25

Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17